University of Shizuoka · Graduate School of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences · 教授

Research keywords28-O2PM-05 TPF・30P1-139 5-FU・ABCB1 and ABCC2 genetic・II trial of the・II trial of triplet・DNA Aptamer Affinity Purification・IN PATIENTS RECEIVING CONCOMITANT・ADMINISTRATION OF DOCETAXEL AND・RETROSPECTIVE ANALYSIS OF NEUTROPENIA・22-11-S29-4

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• An Artifact Derived from a Pseudogene Led to the Discovery of MicroRNA Binding Site Polymorphism in the 3 '-Untranslated Region of the Human Dihydrofolate Reductase Gene
• A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype
• Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer
• Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy

• がん関連抗原CSPG4特異的自己抗体を指標とした早期診断・予後予測システムの構築
• がん化学療法に伴う悪心・嘔吐発現の性差及び個人差の解明と包括的リスク因子解析
• 細胞外マトリックスCSPG4を分子標的としたがん治療戦略の構築
• 遺伝子多型情報に基づく個別化制吐療法の確立

• Official profile